Zuin Marco, Rigatelli Gianluca
Section of Internal and Cardiopulmonary Medicine, Department of Medical Science, University of Ferrara, Ferrara, Italy; Department of Cardiology, Rovigo General Hospital, Rovigo, Italy.
Section of Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Rovigo, Italy.
Cardiovasc Revasc Med. 2018 Jan;19(1 Pt A):57-64. doi: 10.1016/j.carrev.2017.07.003. Epub 2017 Jul 11.
The treatment of coronary artery bifurcation often represents a challenge for interventional cardiologist. Although several stenting techniques are available for the treatment of de novo coronary bifurcation lesions, over the last years, different studies have proposed and analysed the use of drug-coated balloon (DCB) in the treatment of coronary artery bifurcation lesions as an alternative treatment. To date, even considering those studies which have analysed a combined strategy (DCB+stenting) or a DCB-only approach, the evidences are scant and the results debatable. We review the available scientific data regarding the use of DCB in the treatment of naive coronary bifurcation lesions.
冠状动脉分叉病变的治疗对介入心脏病学家来说常常是一项挑战。尽管有几种支架置入技术可用于治疗初发冠状动脉分叉病变,但在过去几年中,不同的研究提出并分析了使用药物涂层球囊(DCB)作为冠状动脉分叉病变的替代治疗方法。迄今为止,即使考虑那些分析了联合策略(DCB+支架置入)或单纯DCB方法的研究,证据也很少,结果也存在争议。我们回顾了有关使用DCB治疗初发冠状动脉分叉病变的现有科学数据。